Last Updated:
Name Designation Appointment Date Status
Gaurav Ajay Saraf

Appointed as Director since July 2022

Director 13-Jul-2022 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Vaibhav Saraf

Appointed as Managing Director since July 2022

Managing Director 13-Jul-2022 Current
Gunja Gaurav Saraf

Appointed as Director since July 2022

Director 13-Jul-2022 Current

People Timeline

Explore the timeline of key personnel in G-Rish Pharma Private Limited's leadership journey.

Loading...
Contact Details
  • Address Office No. 337 & 338, Bombay Oil Seeds, Plot No. 2, 3 & 4, Sector 19A, Vashi,, Navimumbai Maharashtra, 400705, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
How can I contact G-Rish Pharma Private Limited?
You can contact G-Rish Pharma Private Limited through their registered address at Office No. 337 & 338, Bombay Oil Seeds, Plot No. 2, 3 & 4, Sector 19A, Vashi,, Navimumbai Maharashtra, 400705, India, or via their website at g-rishpharma.com. Social media links are also provided where applicable.
Who are the current directors of G-Rish Pharma Private Limited?
The current directors of G-Rish Pharma Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • VAIBHAV SARAF
  • GAURAV AJAY SARAF
  • Gunja Gaurav Saraf
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available